Essentials · Evidence reviewed
Can GLP-1 medicines change how your other medications work?
When starting a weight-loss medicine, one easily missed question is whether it affects medication you already take. Wegovy and Zepbound can slow stomach emptying, potentially changing how certain oral medicines are absorbed. The actual concern depends on your complete medication list and the formulation involved.
Why does stomach emptying matter?
Medicines swallowed by mouth need to move through the digestive tract before being absorbed. Semaglutide and tirzepatide delay gastric emptying, creating a potential interaction with some medicines even when there is no direct chemical reaction between drugs.
Are all oral prescriptions affected?
No. The official Wegovy label describes studies in which several oral drugs did not show clinically important changes, but it also documents increased levothyroxine exposure with semaglutide tablets in a specific interaction study. Study findings cannot be generalized to every formulation or dose.
Which medicines deserve a closer look?
Zepbound labeling advises caution with oral drugs needing tightly controlled blood levels, including warfarin. People taking insulin or insulin-releasing diabetes medicines may also need a hypoglycemia plan. The precise precautions differ by product.
What should you discuss with your pharmacist?
Bring an accurate list of prescription medicines, over-the-counter products and supplements. Include timing of doses and symptoms that have changed after starting or escalating treatment. A pharmacist can identify which medicines warrant monitoring.
What should you avoid?
Don't independently discontinue medicines, shift thyroid replacement or anticoagulant doses, or assume a medication interaction from an online anecdote. Review the label for your exact medicine and route of administration.
The bottom line
Some interactions are formulation-specific. A complete medication review is more useful than a blanket list of drugs to avoid.
Written and published by MyDosePro as an educational explanation of publicly available evidence. The linked primary source is dated 2026-06-01. We identify trial registrations separately from published results and do not provide individual prescribing advice.
Primary sourceWegovy FDA prescribing information ↗
Additional evidenceThis guide explains published evidence; source dates may be older than the review date. Our interpretation is educational and does not replace medical or insurance advice.